BBA-17426-02926
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 181 / PA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Moderna
-
2021-01-05
Registered in v-safe
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-03
Dose 2 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Gestational hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Developed gestational hypertension.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-26
Survey response — day 21, dose 2MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Developed pre-ecclampsia.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-03
- 2021-03-10
- 2021-03-13
- 2021-03-17
- 2021-04-28
- 2021-05-05
- 2021-08-04
-
2021-11-22
Dose 3 — Moderna
- 2022-02-03
- 2022-02-21
-
2022-05-23
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID at the beginning of March.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-03 | Moderna | |
| 3 | 2021-11-22 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — day 14, dose 2
Symptoms: Developed gestational hypertension.
Release 4 — day 21, dose 2
Symptoms: Developed pre-ecclampsia.
Release 11 — 6 months, dose 3
Symptoms: I had COVID at the beginning of March.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gestational hypertension | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release